Maryam Hamdollah‐Zadeh

Author

Also Known As

M Hamdollah-Zadeh, M. Hamdollah-Zadeh, Maryam A. Hamdollah-Zadeh, Maryam Akram Hamdollah‐Zadeh, Maryam Hamdollah-Zadeh, Maryam Hamdollah‐Zadeh, R. Groome

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of Bristol University of Nottingham Queen Mary University of London Nottingham University Hospitals NHS Trust University of Oxford

About

Maryam Hamdollah‐Zadeh is an author at University of Bristol specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.5K
2	Cell Biology	3	3	377
3	Engineering	1	1	53
4	Health Sciences	1	1	83
5	Natural Sciences	1	1	241

Maryam Hamdollah‐Zadeh

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing Elianna Amin, Sebastian Oltean, Jing Hua, Cancer Cell Developmental BiologyAngiogenesisNatural SciencesDownstream Angiogenesis TargetFibroblast Growth Factor	2011	241
Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer A Mavrou, Karen Brakspear, Maryam Hamdollah‐Zadeh, Oncogene UrologyMedicineReceptor Tyrosine KinaseTherapeutic StrategyProstatic Disease	2014	159
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Recombinant human VEGF165b protein is an effective anti-cancer agent in mice Emma Rennel, Maryam Hamdollah‐Zadeh, E.R. Wheatley, European Journal of Cancer Tumor BiologyMedicineCell ProliferationEffective Anti-cancer AgentRadiation Oncology	2008	83
Detection of VEGF-Axxxb Isoforms in Human Tissues David O. Bates, Athina Mavrou, Yan Qiu, PLoS ONE EngineeringPathologySplicing VariantAngiogenesisBone Morphogenic Protein	2013	53
BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling Bettina C. Urban, T J Collard, Catherine Eagle, Gut	2015	52

Page 1